Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 129Xe MRI for Pulmonary Hypertension in ILD and SSc
NCT07821398Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Apr 2030
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in interstitial lung disease (ILD), pulmonary hypertension (PH), systemic sclerosis (SSc). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
interstitial lung disease (ILD)pulmonary hypertension (PH)systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07821398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821398.